Shruthi Suryaprakash, MD, is a bone marrow transplant physician at St Jude Children’s Research Hospital specializing in transplant and gene therapy for non-malignant hematological diseases. She also serves as an instructor in the Department of Hematology.
Born in Singapore, she completed her Bachelor of Engineering degree at Nanyang Technological University before earning her Doctor of Medicine from Duke NUS Medical School. She completed her residency at Children’s Hospital of Michigan in 2022 before joining St. Jude that same year to begin her clinical fellowship in Pediatric Hematology-Oncology.
Suryaprakash’s experience also extends to several research assistantships at Harvard Medical School, Nanyang and KK Women’s & Children’s Hospital.
Education:
2025 Fellowship, Pediatric Hematology-Oncology – St. Jude Children’s Research Hospital
2022 Residency, Pediatrics – Children’s Hospital of Michigan
2019 Medical Officer, Pediatrics – Ministry of Health Holdings
2016 Doctor of Medicine – Duke NUS Medical School
2012 BE, Chemical and Biomolecular Engineering – Nanyang Technological University
Publications:
Holland EM, Suryaprakash S, Bi Y, Patwardhan A, Keerthi D, Morin CE, Chan S, Selukar S, Sharma A. Imaging biomarkers to predict the development of sinusoidal obstruction syndrome of the liver in pediatric hematopoietic cell transplant recipients. Bone Marrow Transplant May 1;61(5):605-607, 2026. doi: 10.1038/s41409-026-02815-2. PMID: 41845113.
Sharma A, Suryaprakash S, Johnson LM, Unguru Y. Discontinued therapies for sickle cell disease: Status and future directions. Expert Opin Investig Drugs May 1;35(5):341-349, 2026. doi: 10.1080/13543784.2026.2663116. PMID: 42007797.
Suryaprakash S, Ju Y, Papizan JP, Pruett-Miller SM, Wlodarski MW, Weiss MJ, Han L, Bhoopalan SV. Generation of iPSC and isogenic gene-corrected lines from a patient with RPS7 (c.277_279delGTC)-mutated Diamond-Blackfan anemia syndrome. Stem Cell Res Mar 1;91:103908, 2026. doi: 10.1016/j.scr.2026.103908. PMID: 41529448.
Suryaprakash S, Sun Y, Keerthi D, Qudeimat A, Suliman A, Talleur AC, Obeng E, Mamcarz E, Madden R, Epperly R, Bhoopalan SV, Naik S, Zebley CC, Velasquez MP, Arnold P, Tang L, Gottschalk S, Triplett BM, Sharma A. Donor lymphocyte infusions after HCT are associated with low risk of graft-versus-host disease in pediatric and young adult patients. Blood Immunol Cell Ther Dec 1;1(3):100016, 2025. doi: 10.1016/j.bict.2025.100016. PMID: 42358342.
Bhoopalan SV, Mayuranathan T, Liu N, Mayberry K, Yao Y, Zhang J, Métais JY, Yan KK, Throm RE, Ellis SR, Ju Y, Han L, Suryaprakash S, Palmer LE, Zhou S, Yu J, Cheng Y, Yen JS, Gottschalk S, Weiss MJ. Preclinical development of lentiviral vector gene therapy for Diamond-Blackfan anemia syndrome. Mol Ther Jul 2;33(7):3086-3100, 2025. doi: 10.1016/j.ymthe.2024.12.020. PMID: 39673126.
See more publications from Shruthi Suryaprakash